Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 126Breast Neoplasms 78Neoplasms 48Prostatic Neoplasms 19Fatigue 16Obesity 14Colorectal Neoplasms 13Lung Neoplasms 11Polycystic Ovary Syndrome 10Colonic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Weight Loss 6Ovarian Neoplasms 6Rectal Neoplasms 5Multiple Myeloma 5Lymphedema 5Leukemia 5Inflammation 5Pancreatic Neoplasms 4Overweight 4Multiple Endocrine Neoplasia Type 1 4Lymphoma 4Leukemia, Myeloid, Acute 4Insulin Resistance 4Depression 4Cognitive Dysfunction 4Brain Neoplasms 4Stomach Neoplasms 3Peripheral Nervous System Diseases 3

Interventions

Dexamethasone 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Blood Specimen Collection 4Surveys and Questionnaires 3Prednisone 3Melphalan 3Lenalidomide 3Biopsy, Fine-Needle 3fluciclovine F-18 2carfilzomib 2Positron-Emission Tomography 2Mammography 2Injections 2Immunohistochemistry 2Gemcitabine 2Cytarabine 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2weifuchun 1vistusertib 1venetoclax 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1ofatumumab 1obinutuzumab 1lortalamine 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Disease × Exercise × Clear all
NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

University of Western Ontario, Canada

Phase 2 Completed
7 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡